Picture of Kodiak Sciences logo

KOD — Kodiak Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Kodiak Sciences Inc expected to post a loss of $1.07 a share - Earnings Preview

Kodiak Sciences Inc KOD.OQ KOD.O is expected to  show no change in quarterly revenue when it reports  results on August 12 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Kodiak Sciences Inc is for a loss of $1.07 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and 3 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Kodiak Sciences Inc is $3.50, about 134.3% below its last closing price of $8.20

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.89-0.89-1.09Missed-21.9
Dec. 31 2025-0.89-0.88-0.84Beat5
Sep. 30 2024-0.91-0.90-0.84Beat7.1​
Jun. 30 2024-0.87-0.87-0.86Beat1.4
​​Mar. 31 2024-1.06-1.07-0.82Beat23.2
Dec. 31 2023-0.68-0.77-1.13Missed-46.1​
Sep. 30 2023-1.31-1.21-0.95Beat21.3
Jun. 30 2023-1.00-1.14-1.53Missed-34.1
This summary was machine generated August 8 at 14:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Kodiak Sciences

See all news